| Ytd | 51.84% | |
| 1y | -11.92% |
| Open | 2.40 | Prev Close | 2.39 | Low | 2.40 | High | 2.50 | Mkt Cap | 224.97M |
| Vol | 101.14K | Avg Vol | 1.13M | EPS | -0.35 | P/E | N/A | Forward P/E | -7.14 |
| Beta | 2.07 | Short Ratio | 2.56 | Inst. Own | 79.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 2.55 | 200-d Avg | 2.02 | 1yr Est | 7.17 |
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Codexis (CDXS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate
Codexis (NASDAQ:CDXS) affirms FY2026 sales outlook from $72.000 million-$76.000 million to $72.000 m
Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.10) per share which beat the analyst consensu
Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guida
Codexis (CDXS) possesses the right combination of the two key ingredients for a likely earnings beat
Codexis' technical experts will present at three sessions during the conference:Spotlight Presen
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) a leading prov
Codexis, Inc. delivered strong FY25 results, with revenue up 19% to $70.4M, driven by a $37.8M techn
U.S. stocks declined, with Dow Jones falling over 500 points while NASDAQ and S&P 500 also dropp
U.S. stocks down, Dow falls 500+ points. Energy shares up 0.4%, financial stocks down 1.4%. Jobless
Petco Health and Wellness (WOOF) reported strong Q4 sales, but missed earnings estimates. Other gain
Codexis shares jumped 37.8% in after-hours trading after the company reported a profitable fourth qu
Codexis shares jumped 37.8% in after-hours trading after the company reported a profitable fourth qu
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
Codexis (CDXS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Esti
Codexis (NASDAQ:CDXS) reported quarterly earnings of $0.11 per share which beat the analyst consensu
Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2
Codexis (NASDAQ: CDXS) President and CEO Alison Moore outlined the company's strategic focus on RNA
Codexis, Inc. (NASDAQ:CDXS), a leading provider of enzymatic solutions for efficient and scalable th
REDWOOD CITY, Calif., March 4, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider
REDWOOD CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading prov
REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provi
Federated Hermes Inc. trimmed its holdings in shares of Codexis, Inc. (NASDAQ: CDXS) by 73.2% in the
REDWOOD CITY, Calif., Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider
Codexis (CDXS) has become technically an oversold stock now, which implies exhaustion of the heavy s
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading prov
Codexis, Inc. ( CDXS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Georg
Codexis (CDXS) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after t
Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a let